PhD Service d'Hématologie Clinique et Service d'Onco-Hématologie Pédiatrique ,
Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases, British Journal of Haematology, vol.1, issue.3, pp.317-320, 1988. ,
DOI : 10.2307/2281868
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy., Journal of Clinical Oncology, vol.7, issue.1, pp.50-57, 1989. ,
DOI : 10.1200/JCO.1989.7.1.50
Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens., Journal of Clinical Oncology, vol.11, issue.2, pp.304-313, 1993. ,
DOI : 10.1200/JCO.1993.11.2.304
Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A REPORT BY THE EBMT LEUKAEMIA WORKING PARTY, British Journal of Haematology, vol.7, issue.4, pp.567-574, 1991. ,
DOI : 10.2307/2281868
Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM), British Journal of Haematology, vol.300, issue.2, pp.400-407, 2000. ,
DOI : 10.1038/sj.bmt.1700720
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant, Bone Marrow Transplantation, vol.34, issue.8, pp.721-727, 2004. ,
DOI : 10.1038/sj.bmt.1704645
Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow Transplantation, Journal of Clinical Oncology, vol.19, issue.16, pp.3675-3684, 2001. ,
DOI : 10.1200/JCO.2001.19.16.3675
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia, Bone Marrow Transplantation, vol.18, issue.2, pp.157-162, 2005. ,
DOI : 10.1038/sj.bmt.1701146
Graftversus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients ,
Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation, Bone Marrow Transplant, vol.18, pp.975-980, 1996. ,
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation., Journal of Clinical Oncology, vol.15, issue.2, pp.433-444, 1997. ,
DOI : 10.1200/JCO.1997.15.2.433
Prospective Trial of Chemotherapy and Donor Leukocyte Infusions for Relapse of Advanced Myeloid Malignancies After Allogeneic Stem-Cell Transplantation, Journal of Clinical Oncology, vol.20, issue.2, pp.405-412, 2002. ,
DOI : 10.1200/JCO.2002.20.2.405
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party, Journal of Clinical Oncology, vol.25, issue.31, pp.4938-4983, 2007. ,
DOI : 10.1200/JCO.2007.11.6053
Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-81, 1958. ,
DOI : 10.1214/aoms/1177731566
Multiple Imputation for Nonresponse in Surveys, 1987. ,
DOI : 10.1002/9780470316696
Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group, European Journal of Cancer, vol.47, issue.1 ,
DOI : 10.1016/j.ejca.2010.09.020
Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group, Journal of Clinical Oncology, vol.27, issue.3, pp.377-84, 2009. ,
DOI : 10.1200/JCO.2008.17.6065
Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol, Leukemia, vol.110, issue.9, pp.1599-606, 2010. ,
DOI : 10.1038/leu.2010.153
Childhood leukemia, 2011. ,
DOI : 10.1007/978-3-642-13781-5
Childhood acute myeloid leukaemia, British Journal of Haematology, vol.148, issue.3, pp.259-76, 2012. ,
DOI : 10.1111/bjh.12040
Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment, Blood, vol.126, issue.24, pp.2578-84, 2015. ,
DOI : 10.1182/blood-2015-06-649111
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab, Haematologica, vol.99, issue.7 ,
DOI : 10.3324/haematol.2013.100073
Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis, Oncotarget, vol.6, issue.32, pp.33961-71, 2015. ,
The pharmacology of second-generation chimeric antigen receptors, Nature Reviews Drug Discovery, vol.366, issue.7, pp.499-509, 2015. ,
DOI : 10.1038/nrd4597